UN mobilizes to stop super-bugs

Image
AFP United Nations
Last Updated : Sep 22 2016 | 1:32 AM IST
World leaders today called for governments, medical researchers and consumers to take action to stop super-bugs, which resist antibiotics and are posing a growing threat to public health.
"Anti-microbial resistance poses a fundamental, long-term threat to human health, sustainable food production and development," UN Secretary-General Ban Ki-moon said as he opened a first-of-a-kind meeting on the problem on the sidelines of the UN General Assembly.
"We are losing our ability to protect both people and animals from life-threatening infections," he said.
Super-bugs -- or bacteria that cannot be treated by the current crop of antibiotics and other drugs -- could kill up to 10 million people around the world by 2050, as many as cancer, according to a recent British study.
Ban pointed to the outbreak of a tough strain of typhoid in Africa as well as growing resistance to AIDS treatments and a form of tuberculosis found in 105 countries that has proven impervious to antibiotics.
"Some scientists call it a slow-motion tsunami," said Margaret Chan, director-general of the World Health Organization.
"The situation is bad and getting worse," she said.
"On current trends, a common disease like gonorrhea may become untreatable. Doctors will be forced to say, 'Sorry, I can't do anything for you,'" Chan said, referring to the sexually transmitted malady.
Chan voiced concern that no new range of antibiotics had been developed in years, with the pharmaceutical industry finding the returns on their investment not worth their while.
She urged coordinated action that brings together the public and private sectors, including governments, health professionals, laboratories and also consumers.
For the public, she said that consumers should avoid meat from animals treated with antibiotics, which are commonly administered to livestock to prevent disease but also to maximize growth and profit.
Governments meeting at the United Nations signed onto an agreement to boost controls on antibiotics, step up research on drugs and treatments, and to improve awareness over anti-microbial resistance.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 22 2016 | 1:32 AM IST

Next Story